Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
Yoshikawa, Yusuke
Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies. [electronic resource] - Circulation 02 2018 - 551-562 p. digital
Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't; Validation Study
1524-4539
10.1161/CIRCULATIONAHA.117.028924 doi
Age Factors
Aged
Angina, Unstable--diagnostic imaging
Clinical Decision-Making
Comorbidity
Coronary Artery Disease--diagnostic imaging
Coronary Thrombosis--diagnostic imaging
Decision Support Techniques
Drug Therapy, Combination
Drug-Eluting Stents
Female
Health Status
Hemorrhage--chemically induced
Humans
Incidence
Japan--epidemiology
Male
Middle Aged
Myocardial Infarction--diagnostic imaging
Patient Selection
Percutaneous Coronary Intervention--adverse effects
Platelet Aggregation Inhibitors--administration & dosage
Predictive Value of Tests
Randomized Controlled Trials as Topic
Recurrence
Registries
Reproducibility of Results
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies. [electronic resource] - Circulation 02 2018 - 551-562 p. digital
Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't; Validation Study
1524-4539
10.1161/CIRCULATIONAHA.117.028924 doi
Age Factors
Aged
Angina, Unstable--diagnostic imaging
Clinical Decision-Making
Comorbidity
Coronary Artery Disease--diagnostic imaging
Coronary Thrombosis--diagnostic imaging
Decision Support Techniques
Drug Therapy, Combination
Drug-Eluting Stents
Female
Health Status
Hemorrhage--chemically induced
Humans
Incidence
Japan--epidemiology
Male
Middle Aged
Myocardial Infarction--diagnostic imaging
Patient Selection
Percutaneous Coronary Intervention--adverse effects
Platelet Aggregation Inhibitors--administration & dosage
Predictive Value of Tests
Randomized Controlled Trials as Topic
Recurrence
Registries
Reproducibility of Results
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome